NLRP3 and cryopyrin-associated periodic syndrome: The best described inflammasomopathies result from autosomal dominant gain-of-function mutations in Nlrp3, which drive autoinflammatory diseases known as cryopyrin-associated periodic syndrome (CAPS) [133].